15
Views
3
CrossRef citations to date
0
Altmetric
Original Article

High Field Proton NMR Investigations of the Metabolic Profiles of Multidrug-Sensitive and -Resistant Leukaemic Cell Lines: Evidence for Diminished Taurine Levels in Multidrug-Resistant Cells

, , , , , , & show all
Pages 355-369 | Received 06 Jul 1993, Published online: 07 Jul 2009

References

  • Bachur N. R., Gordon S. I., Gee M. V.A. A general mechanism for microsomal activation of quinone anticancer agents to free radicals. Cancer Research 1978; 38: 1745–1750
  • Halliwell B., Gutteridge J. M.C. The importance of free radicals and catalytic metal ions in human diseases. Molecular Aspects of Medicine 1985; 8: 89–193
  • O'Donnell-Tormey J., Nathan C. F., Lanks K., De Boer C. J., De La Harpe J. Secretion of pyruvate. An antioxidant defense of mammalian cells. Journal of Experimental Medicine 1987; 165: 500–514
  • Reitzer L. J., Wice B. M., Kennell D. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. Journal of Biological Chemistry 1979; 254: 2669–2676
  • Halliwell B., Gutteridge J. M.C. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochemical Journal 1984; 219: 1–14
  • Jiang X. R., Macey M. G., Newland A. C. Multidrug resistance in haematological malignancies. Medical Laboratory Science 1991; 48: 261–270
  • Endicott J. A., Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annual Reviews in Biochemistry 1989; 58: 137–171
  • Yang M., Jiang X. R., Blake D. R., Zhang Z., Macey M. G., Newland A. C., Morris C. J. Involvement of anti-oxidant enzymes in multiple drug resistance in a human T-lymphoblastic leukaemia cell line which over-expresses P-glycoprotein. International Journal of Oncology 1993; 3: 99–104
  • Kramer R. A., Zakher J., Kim G. Role of the glutathione redox cycle in aquired and de novo multidrug resistance. Science 1988; 241: 694–697
  • Black S. M., Wolf C. R. Role of glutathione-dependent enzymes in drug resistance. Pharmacological Therapy 1991; 51: 139–154
  • Bock J. L. Analysis of serum by high-field proton nuclear magnetic resonance. Clinical Chemistry 1982; 28: 1873–1876
  • Bell J. D., Brown J. C., Sadler P. J. NMR studies of body fluids. NMR in Biomedicine 1989; 2: 246–256
  • Grootveld M., Henderson E. B., Farrell A., Blake D. R., Parkes H. G., Haycock P. Oxidative damage to hyaluronate and glucose in synovial fluid during exercise of the inflamed rheumatoid joint: detection of abnormal low-molecular-mass metabolites by proton NMR spectroscopy. Biochemical Journal 1991; 273: 459–467
  • Seguin F., Jubault C., Grivet J. P., Le Pape A. 31P-NMR study of intracellular pH during the respiratory burst of macrophages. Experimental Cell Research 1990; 186: 188–191
  • Neeman M., Degani H. Metabolic studies of estrogen-and tamoxifen-treated human breast cancer cells by nuclear magnetic resonance spectroscopy. Cancer Research 1989; 49: 589–594
  • Berners-Price S. J., Sant M. E., Christopherson R. I., Kuchel P. W. 1H and 31P NMR and HPLC studies of mouse L1210 leukemia cell extracts: the effect of Au(I) and Cu(I) diphosphine complexes on the cell metabolism. Magnetic Resonance in Medicine 1991; 18: 142–158
  • Jiang X. R., Newland A. C., Macey M. G., Jenkins G. C., Miki T., Adachi K., Yamabe S. Evaluation of the in vitro antiproliferative properties of four novel anthracyclines YM1, 3, 4 and 6 in human leukemia cell lines. Journal of Chemotherapy 1992; 4: 306–311
  • Beck W. T., Mueller T. J., Tanzer L. R. Altered surface membrane glycoprotein in vinca alkaloid-resistant human leukemia lymphoblasts. Cancer Research 1979; 39: 2070–2076
  • Yamaguchi K., Sakakibara S., Asamizu J., Ueda I. I. Induction and activation of cysteine oxidation in rat liver. II. Measurement of cysteine oxidase. Biochimica et Biophysica Acta 1973; 297: 48–59
  • Yamaguchi K., Hosokawa Y., Kohashi N., Kori Y., Sakakibara S., Ueda I. Rat liver cysteine dioxygenase (cysteine oxidase). Further purification, characterisation and analysis of activation and inactivation. Journal of Biochemistry (Tokyo) 1978; 83: 479–491
  • Oja S. S., Kontro P. Free amino acids in epilepsy: possible role of taurine. Acta Neurologica Scandinavica 1983; 93(Suppl)5–20
  • Fellman J. H., Roth E. S. The biological oxidation of hypotaurine to taurine: hypotaurine as an antioxidant. “Taurine: Biological Actions and Clinical Perspectives”, E. S. Roth. A.R. Liss, New York 1985; 71–82
  • Fellman J. H., Roth E. S., Avedovech N. A., McCarthy K. D. The metabolism of taurine to isethionate. Archives of Biochemistry and Biophysics 1980; 204: 560–567
  • Fellman J. H., Roth E. S. Hypotaurine aminotransferase. Advances in Experimental Medicine and Biology 1982; 139: 99–113
  • Aruoma O. I., Halliwell B., Hoey B. M., Butler J. The antioxidant action of taurine, hypotaurine and their metabolic precursors. Biochemical Journal 1988; 256: 251–255
  • Callaghan R., van Gorkom L. C.M., Epand R. M. A comparison of membrane properties and composition between cell lines selected and transfected for multi-drug resistance. British Journal of Cancer 1992; 66: 781–786
  • Wright C. E., Tallan H. H., Lin Y. Y., Gaull G. E. Taurine: Biological Update. Annual Reviews in Biochemistry 1986; 55: 427–453
  • Anbar M., Neta P. A compilation of specific bimolecular rate constants for the reaction of hydrated electrons, hydrogen atoms and hydroxyl radicals with inorganic and organic compounds in aqueous solutions. International Journal of Applied Radiation and Isotopes 1967; 18: 493–497
  • Thomas E. L., Grisham M. B., Melton D. F., Jefferson M. M. Evidence for a role of taurine in the in vitro oxidative toxicity of neutrophils toward erythrocytes. Journal of Biological Chemistry 1985; 260: 3321–3329
  • Lewis S. M. The constituents of normal normal blood and bone marrow. “Blood and its Disorders”, R. W. Hardisty, D. J. Weatherall. Blackwell Scientific, Oxford 1982; 3–56

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.